Celleration, Inc, Eden Prairie, Minnesota, developer of the patented MIST Therapy System, an innovative device that uses ultrasound to heal wounds, has named Christopher Geyen, CPA, as chief financial officer (CFO). Geyen has more than 15 years of financial management experience at both private and publicly traded medical device companies. Before joining Celleration, Geyen served as CFO of Restore Medical, Inc. He also served as CFO of Acorn Cardiovascular, Inc, and Urologix, Inc.

[black up pointing small triangle] Information:http://www.celleration.com